Zobrazeno 1 - 10
of 14
pro vyhledávání: '"K. L. Sewell"'
Autor:
I. Ulč, J. David, K. L. Sewell, Jay L. Goldstein, E. Spindel, A. Jungwirthová, S. Searle, J. Škopek, L. Bouchner, J. Grim, F. Pešek
Publikováno v:
Alimentary Pharmacology & Therapeutics. 32:1091-1101
Aliment Pharmacol Ther 2010; 32: 1091–1101 Summary Background Nonsteroidal anti-inflammatory drugs are associated with upper gastrointestinal mucosal injury. Naproxen etemesil is a lipophilic, non-acidic, inactive prodrug of naproxen that is hydrol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2d9e0a8766337d953be785b7f2b4527
https://doi.org/10.1111/j.1365-2036.2010.04442.x
https://doi.org/10.1111/j.1365-2036.2010.04442.x
Publikováno v:
Clinical and Experimental Immunology. 141:141-147
Summary Serological profiles for anti-Saccharomyces cerevisiae antibodies (ASCA)/ perinuclear antineutrophil cytoplasmic antibodies (pANCA) and gene polymorphisms in tumour necrosis factor (TNF)-α and intercellular adhesion molecule-1 (ICAM-1) are a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e6bb919050cb4e1f78ce67ffda2fff
https://doi.org/10.1111/j.1365-2249.2005.02830.x
https://doi.org/10.1111/j.1365-2249.2005.02830.x
Autor:
M. Gaspari, Rosie Z. Yu, F. A. Dorr, C. Barish, D. Dalke, Bruce R. Yacyshyn, K. L. Sewell, J Goff, Joseph A. Tami
Publikováno v:
Alimentary Pharmacology & Therapeutics. 16:1761-1770
Summary Background and aims : To evaluate the safety, pharmacokinetics and clinical efficacy of the intercellular adhesion molecule-1 antisense phosphorothioate oligonucleotide alicaforsen (ISIS 2302) at 250–350 mg in Crohn's disease. Methods : Pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::717ae85c71a3feba076422f638f565d0
https://doi.org/10.1046/j.1365-2036.2002.01341.x
https://doi.org/10.1046/j.1365-2036.2002.01341.x
Autor:
J L, Goldstein, A, Jungwirthová, J, David, E, Spindel, L, Bouchner, F, Pešek, S, Searle, J, Skopek, J, Grim, I, Ulč, K L, Sewell
Publikováno v:
Alimentary pharmacologytherapeutics. 32(9)
Nonsteroidal anti-inflammatory drugs are associated with upper gastrointestinal mucosal injury. Naproxen etemesil is a lipophilic, non-acidic, inactive prodrug of naproxen that is hydrolysed to pharmacologically active naproxen once absorbed. We hypo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::42030ccd5e948d7715bf5898aebdfc92
https://pubmed.ncbi.nlm.nih.gov/20804454
https://pubmed.ncbi.nlm.nih.gov/20804454
Autor:
B R, Yacyshyn, C, Barish, J, Goff, D, Dalke, M, Gaspari, R, Yu, J, Tami, F A, Dorr, K L, Sewell
Publikováno v:
Alimentary pharmacologytherapeutics. 16(10)
To evaluate the safety, pharmacokinetics and clinical efficacy of the intercellular adhesion molecule-1 antisense phosphorothioate oligonucleotide alicaforsen (ISIS 2302) at 250-350 mg in Crohn's disease.: Patients (50 kg) with active Crohn's disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57458d360e1434075f38551b86a91c22
https://pubmed.ncbi.nlm.nih.gov/12269969
https://pubmed.ncbi.nlm.nih.gov/12269969
Autor:
S, Cohen, R M, Levy, M, Keller, E, Boling, R D, Emkey, M, Greenwald, T M, Zizic, S, Wallach, K L, Sewell, B P, Lukert, D W, Axelrod, A A, Chines
Publikováno v:
Arthritis and rheumatism. 42(11)
Risedronate, a new pyridinyl bisphosphonate, is a potent antiresorptive bone agent. This study examines the safety and efficacy of daily, oral risedronate therapy for the prevention of corticosteroid-induced bone loss.This multicenter, randomized, do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9c93f73d6331f2ba00dace955b180c51
https://pubmed.ncbi.nlm.nih.gov/10555025
https://pubmed.ncbi.nlm.nih.gov/10555025
Autor:
K L, Sewell
Publikováno v:
Clinics in geriatric medicine. 14(3)
Rheumatoid arthritis is a common problem in older adults with varied clinical presentations, which can present a diagnostic challenge. Patients experience a significant functional decline and are placed at increased risk of institutionalization. Mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e540947d157c437641386bbac74efea2
https://pubmed.ncbi.nlm.nih.gov/9664103
https://pubmed.ncbi.nlm.nih.gov/9664103
Autor:
K L, Sewell
Publikováno v:
Revue du rhumatisme (English ed.). 64
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::df895e460afa656cbf97bf28910d6bb9
https://pubmed.ncbi.nlm.nih.gov/9273940
https://pubmed.ncbi.nlm.nih.gov/9273940
Publikováno v:
Arthritis care and research : the official journal of the Arthritis Health Professions Association. 9(2)
To examine and compare health status and disease activity changes in patients with rheumatoid arthritis (RA) in a clinical trial of the biologic agent DAB486IL-2.Data on 45 patients with RA who were enrolled in a multicourse, double-blind trial, cons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8c3337f9e16506e20fb68a2ad53cf793
https://pubmed.ncbi.nlm.nih.gov/8970269
https://pubmed.ncbi.nlm.nih.gov/8970269
Publikováno v:
The Journal of rheumatology. 20(12)
An inflammatory compartment radionuclide such as Indium-111 chloride (111InCl3) may offer advantages over bone seeking radionuclides in the assessment of active rheumatoid synovitis. As an iron analog, 111InCl3 binds iron complexing proteins includin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8d6a3eac753ff5fe656caa518b7be585
https://pubmed.ncbi.nlm.nih.gov/7837173
https://pubmed.ncbi.nlm.nih.gov/7837173